SCHEMBL5774017

SCHEMBL5774017

CC(C)C(c1ccc(NC(=O)CCc2cnoc2-c2ccc(F)cc2)cc1)(C(C)C)P(=O)(O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.38
MAPT P10636 3/20 0.38
TP53 P04637 3/20 0.38
CNR2 P34972 3/20 0.37
CNR1 P21554 2/20 0.37
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
HTR1A P08908 1/20 0.36
THRB P10828 1/20 0.36
PIM1 P11309 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAOA P21397 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770233 0.88 SMN1; SMN2 (0.40) SMN1; SMN2MAPTTP53CNR2CNR1
SCHEMBL5771355 0.86 MAPT (0.39) SMN1; SMN2MAPTTP53CNR2CNR1
SCHEMBL5773332 0.83 CNR2 (0.51) SMN1; SMN2MAPTTP53CNR2CNR1
SCHEMBL5772289 0.83 MEN1 (0.38) SMN1; SMN2MAPTTP53CNR2CNR1
SCHEMBL5772904 0.80 TP53 (0.48) SMN1; SMN2MAPTTP53CNR2NPC1
SCHEMBL5774020 0.80 MAPT (0.42) SMN1; SMN2MAPTCNR2CNR1GLA
SCHEMBL5770399 0.80 MAPT (0.40) SMN1; SMN2MAPTTP53CNR2CNR1
SCHEMBL5775516 0.79 MAPT (0.41) SMN1; SMN2MAPTTP53TSHRNPC1
SCHEMBL5777386 0.79 LMNA (0.47) SMN1; SMN2MAPTCNR2LMNAHTT
SCHEMBL5775864 0.79 SMN1; SMN2 (0.47) SMN1; SMN2MAPTTP53CNR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR SMN1; SMN2 3383/4885MAPT 4701/4885TP53 4371/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 SMN1; SMN2 2449/4885MAPT 4763/4885TP53 4446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.